Crossmark

Exploration of the potential therapeutic benefits of naringenin against diabetic retinopathy through a National comprehensive cross-sectional study and in vitro experiments

Crossref DOI link: https://doi.org/10.1186/s13098-025-01879-2

Published Online: 2025-08-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Yuan

Cao, Yihong

Zhu, Weigen

Huang, Zhengru
Funding

Funding for this research was provided by:

Jiangsu University Medical Education Collaborative Innovation Project fund (JDYY2023100)

Changshu Guiding Project in Health Science and Technology (CSWSD202310)
License Information

Text and Data Mining valid from 2025-08-01

Version of Record valid from 2025-08-01
More Information

Article History

Received: 28 April 2025

Accepted: 25 July 2025

First Online: 1 August 2025

Declarations

:

: The protocol of NHANES has been approved by the Ethics Review Board of NCHS and all participants completed written informed consent.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below